Our teams of scientists and technological experts collaborate with the global scientific community to democratize the drug development process and help our clients dramatically improve the success rate of pre-clinical drug candidates. Academic and biotech partners in the thriving TandemAI ecosystem share our dedication to improving the lives of patients waiting for new treatment options.
Committed to Collaboration
The TandemAI commitment to democratizing drug discovery includes our participation in open-source communities where we collaborate with partners to continually improve drug discovery tools. As improvements arise, we share scientific advances with our partners and with the global scientific community. We make our software tools available to meet the needs of clients and do not sell applications as stand-alone, licensed products.